BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21041491)

  • 1. Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.
    Tippayawat P; Pinsiri M; Rinchai D; Riyapa D; Romphruk A; Gan YH; Houghton RL; Felgner PL; Titball RW; Stevens MP; Galyov EE; Bancroft GJ; Lertmemongkolchai G
    Infect Immun; 2011 Jan; 79(1):305-13. PubMed ID: 21041491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.
    Tippayawat P; Saenwongsa W; Mahawantung J; Suwannasaen D; Chetchotisakd P; Limmathurotsakul D; Peacock SJ; Felgner PL; Atkins HS; Titball RW; Bancroft GJ; Lertmemongkolchai G
    PLoS Negl Trop Dis; 2009; 3(4):e407. PubMed ID: 19352426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.
    Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S
    Front Immunol; 2021; 12():767359. PubMed ID: 34966388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.
    Chu KK; Tippayawat P; Walker NJ; Harding SV; Atkins HS; Maillere B; Bancroft GJ; Lertmemongkolchai G; Altmann DM
    Eur J Immunol; 2011 Jan; 41(1):107-15. PubMed ID: 21182082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Control of
    Nithichanon A; Rinchai D; Buddhisa S; Saenmuang P; Kewcharoenwong C; Kessler B; Khaenam P; Chetchotisakd P; Maillere B; Robinson J; Reynolds CJ; Boyton RJ; Altmann DM; Lertmemongkolchai G
    Front Immunol; 2018; 9():484. PubMed ID: 29616023
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.
    Nithichanon A; Gourlay LJ; Bancroft GJ; Ato M; Takahashi Y; Lertmemongkolchai G
    Immunology; 2017 May; 151(1):98-109. PubMed ID: 28066900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.
    Sengyee S; Yarasai A; Janon R; Morakot C; Ottiwet O; Schmidt LK; West TE; Burtnick MN; Chantratita N; Brett PJ
    Front Immunol; 2021; 12():698303. PubMed ID: 34394091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
    Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK.
    Gourlay LJ; Thomas RJ; Peri C; Conchillo-Solé O; Ferrer-Navarro M; Nithichanon A; Vila J; Daura X; Lertmemongkolchai G; Titball R; Colombo G; Bolognesi M
    FEBS J; 2015 Apr; 282(7):1319-33. PubMed ID: 25645451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.
    Jenjaroen K; Chumseng S; Sumonwiriya M; Ariyaprasert P; Chantratita N; Sunyakumthorn P; Hongsuwan M; Wuthiekanun V; Fletcher HA; Teparrukkul P; Limmathurotsakul D; Day NP; Dunachie SJ
    PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004152. PubMed ID: 26495852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.
    Reynolds C; Goudet A; Jenjaroen K; Sumonwiriya M; Rinchai D; Musson J; Overbeek S; Makinde J; Quigley K; Manji J; Spink N; Yos P; Wuthiekanun V; Bancroft G; Robinson J; Lertmemongkolchai G; Dunachie S; Maillere B; Holden M; Altmann D; Boyton R
    J Immunol; 2015 May; 194(10):4814-24. PubMed ID: 25862821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin.
    Nithichanon A; Rinchai D; Gori A; Lassaux P; Peri C; Conchillio-Solé O; Ferrer-Navarro M; Gourlay LJ; Nardini M; Vila J; Daura X; Colombo G; Bolognesi M; Lertmemonkolchai G
    PLoS Negl Trop Dis; 2015; 9(7):e0003917. PubMed ID: 26222657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.